+ All Categories
Home > Documents > Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Date post: 16-Jan-2016
Category:
Upload: dennis-harvey
View: 215 times
Download: 0 times
Share this document with a friend
Popular Tags:
21
Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine
Transcript
Page 1: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Epidemiology of sight loss in the UK

Astrid Fletcher

London School of Hygiene & Tropical Medicine

Page 2: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Overview

• What do we know about the prevalence of sight loss in the UK

• What are the major conditions leading to sight loss?

• Do we need more research?• What are the gaps in knowledge? • What are the main research questions

arising from the data on prevalence and causes?

Page 3: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Use of prevalence data

• Prevalence defined as proportion of people with sight loss at a specific time point

• Describes the relative importance of a health problem in the population

• Usually reported for different age groups• Prevalence rates applied to age specific

population data provide estimates of number of people affected

• Knowledge of prevalence and numbers by causes of sight loss is important for planning services and identifying unmet need

Page 4: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Prevalence estimates of sight loss are only the first step

Largely uninformative without data on the underlying conditions leading to sight loss

Page 5: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Approaches to measurement and categorisation of sight loss

• Vision difficultiesSelf report of difficulties with vision related functions ranging from single item questions to disability scales

• Vision related quality of life scales Describe the impact of vision problems on

everyday functioning and well-being • Clinical measures

“Objective” measures eg Distance and near acuity, visual fields etc

Page 6: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Definition of visual impairment

• WHO cut-points are based on best eye and after full refraction– Visual impairment <6/18 – Low vision <6/18 to 3/60 – Blindness <3/60

• Definitions used in UK studies – <6/12 (approximates to UK driving requirement)– <6/18 & <3/60– Presenting or pinhole corrected or after refraction

Page 7: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Prevalence of best-corrected visual acuity <6/12 in population-based studies

Congdon et al Arch Ophthalmol 1998

Page 8: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Surveys of adult population in the UK using visual acuity measurements

Survey

Setting

Age Number

Response

Lavery 1988 Melton

Mowbray GP

76+ 529

78%

Wormald 1992

Inner London GP

65+ 207 72%

Reidy 1998 N. London

17 GP practices

65+ 1547 84%

National Diet & Nutrition Study 2000

Postcode sampling

& Sample of nursing

homes

65+ 1,362

75% private households

94% nursing homes

MRC Assessment trial 2002

53 GPs across GB

75+ 14,600 69%

Page 9: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Prevalence of VI and blindness

0

5

10

15

20

25

30

35

40

45

Age

Pre

vale

nce VI M

VI F

Blind M

Blind F

MRC Assessment Trial Prevalence of binocular visual impairment

(<6/18) and blindness (<3/60)

74-79 80-84 85-89 90+

Page 10: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Study Age V.I. N %<6/18

%<6/12

Lavery 76+ Refraction 474 26.2 -

Wormald 75+ Refraction 106 14.2 21.8

North London 65+ Presentingbilateral

1547 - 30.2

NDNS 75+ Pinhole 1362 15.2 32.4

MRC 75+ Presentingbinocular

14600 12.410.8-13.9

20.117.8-22.0

UK studies: prevalence visual acuity

Page 11: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Study Age V.I. N %<6/18

NDNS 75+ Pinhole 1362 15.2

MRC 75+ Presentingbinocular

14600 12.410.8-13.9

Rotterdam 75+ Refraction 1806 4.7

Baltimore 70+ Refraction 836 4.8

Beaver Dam 75+ Refraction 795 6.0

Blue Mountains

70+ Refraction 783 5.0

Melbourne 70+ Refraction 605 6.2

Comparison with other non UK studies: VA <6/18 in 75+

Page 12: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Variation in estimates between studies

• Definitions• Measurement quality • Age structure

– especially in oldest age groups where prevalence is highest

• Sampling error – Small numbers in older age groups

May be “true” differences between populations

Page 13: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

What is the significance of differences in prevalence between

populations?

• Variations in prevalence reflect variation in the prevalence of underlying conditions– Availability and use of eye care services– Aetiology of specific eye problems in

different populations

Page 14: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Comparison between UK and non UK studies

• Most non UK studies use only best corrected visual acuity

• Exclude data on vision impairment due to refractive error

• Presenting vision is the most appropriate measure of a person’s everyday vision

• Recommended by WHO in 2003 that presenting VA <6/18 be used as the main definition of visual impairment

Page 15: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

MRC TrialCauses of visual impairment (VA

<6/18) aged 75+

31.6

32.6

20.46.4

2.1

2.6

3.8

Refractive error

AMD

Cataract

Glaucoma

Diabetic eyedisease

Myopic deg

OtherPrevalence of VA <6/18 excluding RE = 8%

Page 16: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Comparison with other studies – blindness (VA <3/60)

0%

20%

40%

60%

80%

100%

Other

Diabetes

Glaucoma

Cataract

AMD

Page 17: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Comparison with other studies - low vision (VA <6/18-3/60)

0%

20%

40%

60%

80%

100%

Other

Diabetes

Glaucoma

Cataract

AMD

Page 18: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Visual impairment in older people

50% to 70% of visual impairment in the older age group is due to “remediable” causes and could be improved by:

specs/ new specs

cataract surgery

Page 19: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Visual impairment in older people

Often not known to health services

Of people aged >65 (Reidy et al 1999):• only 12% of people with cataract were in touch with eye services• only one third of those with uncorrected refractive error had seen an optician in the past 12 months

Page 20: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

MRC assessment trial

• Of people eligible for referral to an ophthalmologist around a half were referred by the GP

• Among those referred, 88% attended• Over 80% of people advised to see an

optician did so• New lenses were obtained by 45%• The main reasons given for not obtaining

glasses were ‘not needed’ and cost

Page 21: Epidemiology of sight loss in the UK Astrid Fletcher London School of Hygiene & Tropical Medicine.

Should new evidence on prevalence and causes of vision

impairment be a research priority?

• Probably not for the older age group. Evidence is reasonably consistent with other developed countries

• Lack information on ethnic minorities in whom prevalence of VI, underlying causes and eye care use may be different from the majority population

• Evaluation of strategies to reduce the high proportion of untreated remediable conditions should be priority for action


Recommended